Chromatin structure changes suggest a compensatory response to c-myc gene amplification in malignant fibrous histiocytoma

1992 ◽  
Vol 49 (2) ◽  
pp. 148-156 ◽  
Author(s):  
Jane S. Gibson ◽  
Byron P. Croker
Keyword(s):  
Gene Amplification ◽  
Malignant Fibrous Histiocytoma ◽  
Chromatin Structure ◽  
Fibrous Histiocytoma ◽  
Compensatory Response ◽  
Structure Changes ◽  
Myc Gene

MDM2 gene amplification in a pediatric malignant fibrous histiocytoma (MFH)

1995 ◽  
Vol 84 (2) ◽  
pp. 144
Author(s):  
J.L. Wilson ◽  
S. Masui ◽  
J.S. Lim ◽  
D. Kalousek ◽  
D. Horsman ◽  
...  
Keyword(s):  
Gene Amplification ◽  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma ◽  
Mdm2 Gene

MDM2 gene amplification in a pediatric malignant fibrous histiocytoma (MFH)

1995 ◽  
Vol 28 (3) ◽  
pp. 363
Author(s):  
J.L. Wilson ◽  
S. Masui ◽  
J.F. Lim ◽  
D. Kalousek ◽  
D. Horsman ◽  
...  
Keyword(s):  
Gene Amplification ◽  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma ◽  
Mdm2 Gene

MR Imaging Findings of Malignant Fibrous Histiocytoma of Bone

1996 ◽  
Vol 34 (2) ◽  
pp. 257
Author(s):  
Jeong Hoon Lee ◽  
Ki Soo Kim ◽  
Byung Hee Lee ◽  
Young Soo Do ◽  
Kie Hwan Kim ◽  
...  
Keyword(s):  
Mr Imaging ◽  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma ◽  
Imaging Findings

Malignant Fibrous Histiocytoma

1976 ◽  
Vol 38 (6) ◽  
pp. 910-919 ◽  
Author(s):  
Makoto HORI ◽  
Kazuki MAEZIMA ◽  
Katsutaro NISHIMOTO ◽  
Kazuya EGAMI ◽  
Gyoogi SATOMI ◽  
...  
Keyword(s):  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma

Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis

Pathology ◽  
1990 ◽  
Vol 22 (1) ◽  
pp. 16-19 ◽  
Author(s):  
Julia A. Bridge ◽  
Warren G. Sanger ◽  
James R. Neff ◽  
Michelle M. Hess
Keyword(s):  
Lung Metastasis ◽  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma

Primary malignant fibrous histiocytoma of the uterus — ultrastructural and immunocytochemical studies of two cases

Pathology ◽  
1985 ◽  
Vol 17 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Sheung-To Chou ◽  
D. Fortune ◽  
N.A. Beischer ◽  
G. McLeish ◽  
L.A. Castles ◽  
...  
Keyword(s):  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma ◽  
Immunocytochemical Studies

Malignant Fibrous Histiocytoma in Childhood

1987 ◽  
Vol 7 (3) ◽  
pp. 303-318 ◽  
Author(s):  
Craig Zuppan ◽  
Gary Mierau ◽  
Harry Wilson
Keyword(s):  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma

LOCAL RECURRENCES AFTER THE TREATMENT OF SOFT TISSUE MALIGNANT FIBROUS HISTIOCYTOMA (UNCLASSIFIEDPLEOMORPHIC SARCOMA) OF THE LIMBS

2019 ◽  
Vol 72 (8) ◽  
pp. 1523-1526
Author(s):  
Oleksandr O. Lytvynenko ◽  
Volodymyr F. Konovalenko ◽  
Anton Yu. Ryzhov
Keyword(s):  
Soft Tissue ◽  
Malignant Fibrous Histiocytoma ◽  
Fibrous Histiocytoma ◽  
Survival Rates ◽  
Soft Tissue Sarcomas ◽  
Primary Treatment ◽  
Radical Excision ◽  
Local Recurrences ◽  
Results Of Treatment

Introduction: The treatment of patients with malignant fibrous histiocytoma as well as other soft tissue sarcomas is not sufficiently effective up to date, and has largely changed and reflects the alterations, occurred in oncology as a whole. The number of amputation decreased over the last 10-15 years. Some researchers associate the improvement of treatment outcomes with the development of combined and complex methods. The aim of the study is an improvement of the results of treatment of patients with soft tissue malignant histiocytoma on the basis of determination of factors, influencing local recurrence development. Materials and methods: The basis of our study was a comprehensive analysis of examination and treatment results of 130 patients with MFH of the soft tissue of limbs, of them in 84 patients (64.6%) the recurrences developed. The group included 45 (53.6%) males and 39 (46.4%) females. The major part of patients – 82.1% (60 patients) were older than 40 years. Results and conclusions: The number of recurrences after the treatment in general surgical facilities is 86.9%, whereas in the patients after the treatment in the specialized oncological facilities this figure is twice lower (40%). The characteristic of the medical facility where the patient receives his/her primary treatment largely affects the development of local recurrences, patients’ quality of life and overall survival rates. The surgical method remains the leading modality in the treatment of MFH of ST. Wide and radical excision of tumors in the specialized oncological facilities allows achieving better survival outcomes of the patients.

Sign in / Sign up

Export Citation Format

Share Document